Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Wall Street
Price Targets
Price Targets Summary
Beijing Tong Ren Tang Chinese Medicine Co Ltd
According to Wall Street analysts, the average 1-year price target for Beijing Tong Ren Tang Chinese Medicine Co Ltd is 15.78 HKD with a low forecast of 12.98 HKD and a high forecast of 19.48 HKD.
Price Targets
Revenue
Forecast
Revenue Estimate
Beijing Tong Ren Tang Chinese Medicine Co Ltd
For the last 8 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's revenue is 6%. The projected CAGR for the next 3 years is 16%.
Operating Income
Forecast
Operating Income Estimate
Beijing Tong Ren Tang Chinese Medicine Co Ltd
For the last 8 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's operating income is 4%. The projected CAGR for the next 3 years is 21%.
Net Income
Forecast
Net Income Estimate
Beijing Tong Ren Tang Chinese Medicine Co Ltd
For the last 8 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's net income is 5%. The projected CAGR for the next 3 years is 17%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's stock price target?
Price Target
15.78
HKD
According to Wall Street analysts, the average 1-year price target for Beijing Tong Ren Tang Chinese Medicine Co Ltd is 15.78 HKD with a low forecast of 12.98 HKD and a high forecast of 19.48 HKD.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Revenue forecast?
Projected CAGR
16%
For the last 8 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's revenue is 6%. The projected CAGR for the next 3 years is 16%.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Operating Income forecast?
Projected CAGR
21%
For the last 8 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's operating income is 4%. The projected CAGR for the next 3 years is 21%.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Net Income forecast?
Projected CAGR
17%
For the last 8 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's net income is 5%. The projected CAGR for the next 3 years is 17%.